Azenta to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 22, 2022. The event will feature a presentation at 3:00 PM ET in a virtual format, accessible via Azenta's investor relations website.

Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services for drug development and clinical research. The company rebranded from Brooks Automation, Inc. on December 1.

News Market Reaction – AZTA

-3.91%

-3.91% Session move

In the trading session that priced this news, AZTA declined 3.91%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHELMSFORD, Mass., March 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, which includes a presentation beginning at 3:00pm ET. The conference will be held in a virtual environment. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).

Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Azenta Life Sciences
978.262.2635
sara.silverman@azenta.com

Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-keybanc-capital-markets-life-sciences--medtech-investor-forum-301500722.html

SOURCE Azenta

FAQ

When will Azenta participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?

Azenta will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 22, 2022.

What time is Azenta's presentation at the investor forum?

Azenta's presentation at the investor forum is scheduled for 3:00 PM ET on March 22, 2022.

How can investors access Azenta's presentation at the forum?

Investors can access Azenta's presentation through the investor relations website at https://investors.azenta.com/events.

What services does Azenta provide in the life sciences sector?

Azenta provides cold-chain sample management and genomic services for drug development, clinical research, and advanced cell therapies.

What was Azenta's previous name before the rebranding?

Azenta was previously known as Brooks Automation, Inc. before rebranding on December 1, 2021.